Skip to main content

Autologous Bone Marrow Transplantation in Solid Malignancies

  • Chapter

Part of the book series: Developments in Hematology and Immunology ((DIHI,volume 19))

Abstract

The natural resistance of a fraction of cells in a tumor to a conventional dose of chemotherapy can partly be overcome by high dose (HD) chemotherapy [1]. HD chemotherapy may kill more tumor cells but could also cause long lasting or irreversible bone marrow aplasia.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lazarus HM, Herzig RH, Wolff SN et al. Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantation. Cancer Treat Rep 1985;69:473–7.

    PubMed  CAS  Google Scholar 

  2. Gorin NC, Herzig G, Bull MI, Graw RG. Long-term preservation of bone marrow and stem cell pool in dogs. Blood 1978;51:257–65.

    PubMed  CAS  Google Scholar 

  3. Thomas ED, Buckner CD, Clift RA. Marrow transplantation for acute non-lymphoblastic leukemia in first remission. N Engl J Med 1979;300:597–9.

    Article  Google Scholar 

  4. Deisseroth A, Abrams RA. The role of autologous stem cell reconstitution in intensive therapy for resistant neoplasms. Cancer Treat Rep 1979;63:461–71.

    PubMed  CAS  Google Scholar 

  5. De Vries EGE, Vriesendorp R, Meinesz AF, Mulder NH, Postmus PE, Sleijfer DTh. No narcosis for bone marrow harvest in autologous bone marrow transplantation. Blut 1984;49:419–21.

    Article  PubMed  Google Scholar 

  6. Arnaud F, Orie JML, Mulder NH et al. Bone marrow separation, purification and cryopreservation: application for autologous bone marrow transplantation (ABMT). Int J Art Org 1985;8:209–14.

    CAS  Google Scholar 

  7. Elias MK, Oenema B, Scholten JT, Das PC, Smit Sibinga CTh. Surge pump plateletapheresis: a method for effective depletion of white cells from machine collected single donor platelets. Plasma Ther Transf Ther 1985;6:381–96.

    Google Scholar 

  8. von Bartheld M, Arnaud F, Das PC, Smit Sibinga CTh. Cryopreservation of platelet concentrate: a comparison of DMSO and glycerol systems. In: Smit Sibinga CTh, Das PC, van Loghem JJ (eds). Blood transfusion and problems of bleeding. The Hague/Boston/London: Martinus Nijhoff Publishers 1982:89–95.

    Google Scholar 

  9. Philip T, Biron P, Maraninchi D et al. Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non-Hodgkin’s lymphoma. Brit J Haemat 1985;60:599–609.

    Article  PubMed  CAS  Google Scholar 

  10. De Kraker J. Voute PA. The effect of high dose melphalan with autologous bone marrow transplantation in neuroblastoma patients with advanced disease. In: McVie JG, Dalesio O, Smith IE (eds). Autologous bone marrow transplantation and solid tumors. Raven Press 1984:153–6.

    Google Scholar 

  11. Postmus PE, Mulder NH, Sleijfer DTh, Meinesz AF, Vriesendorp R, de Vries EGE. High-dose etoposide for refractory malignancies: a phase I study. Cancer Treat Rep 1984;68:1471–4.

    PubMed  CAS  Google Scholar 

  12. McElwain TJ, Hedley DW, Burton G et al. Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high dose melphalan. Br J Cancer 1979;40:72–80.

    Article  PubMed  CAS  Google Scholar 

  13. Scheef W, Klein HO, Brock N et al. Controlled clinical studies with an antidote against the urotoxicity of oxazophophorines: Preliminary results. Cancer Treat Rep 1979;63:501–5.

    PubMed  CAS  Google Scholar 

  14. Smith IE, Evans BD, Harland SJ, Millar JL. Autologous bone marrow rescue is unnecessary after very-high-dose cyclophosphamide. Lancet 1983;i:76–7.

    Article  Google Scholar 

  15. Spitzer G, Verma DS, Fisher R et al. The myeloid progenitor cell — its value in predicting hematopoietic recovery after autologous bone marrow transplantation. Blood 1980;55:317–23.

    PubMed  CAS  Google Scholar 

  16. Hartmann O, Beaujean F, Bayet S et al. Hematopoietic recovery following autologous bone marrow transplantation: Role of cryopreservation, number of cells infused and nature of high-dose chemotherapy. Eur J Cancer Clin Oncol 1985;21: 53–60.

    Article  PubMed  CAS  Google Scholar 

  17. Millar JL, Smith IE. The viability of marrow stored at 4°C. In: McVie JG, Dalesio O, Smith IE (eds). Autologous bone marrow transplantation and solid tumors. Raven Press 1984:9–12.

    Google Scholar 

  18. Patterson J, Prentice HG, Brenner MK et al. Graft rejection following HLA matched T-lymphocytes depleted bone marrow transplantation. Brit J Haemat 1986;63:221–30.

    Article  PubMed  CAS  Google Scholar 

  19. Shiobara S, Harada M, Mori T et al. Difference in posttransplant recovery of immune reactivity between allogeneic and autologous bone marrow transplantation. Transplant Proc 1982;15:429–33.

    Google Scholar 

  20. Gouyette A, Hartmann O, Pico GI. Pharmacokinetics of high-dose melphalan in children and adults. Cancer Chemother Pharmacol 1986;16:184–9.

    Article  PubMed  CAS  Google Scholar 

  21. Holthuis JJM, Postmus PE, van Oort WJ et al. Pharmacokinetics of high dose etoposide (VP 16–213). Proc Am Ass Clin Oncol 1986:5(abstract 113).

    Google Scholar 

  22. Postmus PE, Mulder NH, Elema JD. Graft versus host disease in autologous bone marrow transplantation. Cancer 1987 (in press).

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Mulder, P.O.M. et al. (1987). Autologous Bone Marrow Transplantation in Solid Malignancies. In: Sibinga, C.T.S., Das, P.C., Engelfriet, C.P. (eds) White cells and platelets in blood transfusion. Developments in Hematology and Immunology, vol 19. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2089-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2089-0_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9238-8

  • Online ISBN: 978-1-4613-2089-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics